Individual and family medical and dental insurance plans are insured by Cigna Health and Life Insurance Company (CHLIC). In Arizona, individual HMO plans are insured by Cigna HealthCare of Arizona, Inc. Group health insurance and health benefit plans are insured or administered by CHLIC, Connecticut General Life Insurance Company (CGLIC), or their affiliates (see a listing of the legal entities that insure or administer group HMO, dental HMO, and other products or services in your state). Group Universal Life (GUL) insurance plans are insured by CGLIC. Life (other than GUL), accident, critical illness, and disability plans are insured or administered by Life Insurance Company of North America, except in NY, where insured plans are offered by Cigna Life Insurance Company of New York. All insurance policies and group benefit plans contain exclusions and limitations. For availability, costs and complete details of coverage, contact a licensed agent or Cigna sales representative. This website is not intended for residents of New Mexico.
At 18, fresh from high school, Marina, Ignacio, Adam and Mimi, school mates bonded by fate, shared a dream about adult life, a dream of fame, success, perfect skin and that one endless, true love that, surely, was waiting just around the corner for each one of them. But 30's arrived, and none of the sweet promises of youth was fulfilled. Alone, failed and frustrated, all four are forced to stop and look around to try to understand where it all went wrong, and find an emergency fix for their lives, before it's too late, and happiness escapes through their fingers forever. Secondary Effects is the bitter coming of age comedy that follows their steps in the search for lost dreams, lost hair and good sex, at least, if true love turns out to be a mirage. Written by Anonymous
Mefloquine is a chiral molecule with two asymmetric carbon centres, which means it has four different stereoisomers . The drug is currently manufactured and sold as a racemate of the ( R , S )- and ( S , R )-enantiomers by Hoffman-LaRoche , a Swiss pharmaceutical company. Essentially, it is two drugs in one. Plasma concentrations of the (–)-enantiomer are significantly higher than those for the (+)-enantiomer, and the pharmacokinetics between the two enantiomers are significantly different. The (+)-enantiomer has a shorter half-life than the (–)-enantiomer.